Page last updated: 2024-08-24

mizolastine and Conjunctivitis, Allergic

mizolastine has been researched along with Conjunctivitis, Allergic in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ciprandi, G; Cirillo, I; Vizzaccaro, A	1
Bachert, C; Brostoff, J; Murrieta, M; Scadding, GK; Stalla-Bourdillon, A; Tasman, J	1
Attali, P; Ben-Soussen, P; Daele, J; Sabbah, A; Wade, AG	1
Bachert, C; Murrieta-Aguttes, M; Scadding, GK; Tasman, AJ	1
Bachert, C; Margari, P; Murrieta-Aguttes, M; Santoni, JP; Vovolis, V	1

Trials

4 trial(s) available for mizolastine and Conjunctivitis, Allergic

Article	Year
Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge. European annals of allergy and clinical immunology, 2004, Volume: 36, Issue:4 Topics: Adult; Allergens; Anti-Allergic Agents; Benzimidazoles; Conjunctivitis, Allergic; Cytokines; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Interleukin-1; Interleukin-6; Male; Nasal Provocation Tests; Parietaria; Pollen; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Terfenadine; Tumor Necrosis Factor-alpha	2004
Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group. Allergy, 1998, Volume: 53, Issue:10 Topics: Adult; Asthma; Benzimidazoles; Cellulitis; Central Nervous System Diseases; Conjunctivitis, Allergic; Dizziness; Double-Blind Method; Female; Gastrointestinal Diseases; Headache; Histamine H1 Antagonists; Humans; Leukopenia; Male; Middle Aged; Nasal Obstruction; Placebos; Respiratory Tract Diseases; Rhinitis, Allergic, Perennial; Sleep Stages; Treatment Outcome	1998
Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis. MIZOCET Study Group. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1999, Volume: 83, Issue:4 Topics: Adolescent; Adult; Anti-Allergic Agents; Benzimidazoles; Cetirizine; Conjunctivitis, Allergic; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Rhinitis, Allergic, Seasonal; Safety; Time Factors; Treatment Outcome	1999
Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. Riperex Study Group. The Journal of international medical research, 1999, Volume: 27, Issue:6 Topics: Adult; Benzimidazoles; Conjunctivitis, Allergic; Double-Blind Method; Europe; Female; Histamine H1 Antagonists; Humans; Male; Placebos; Rhinitis, Allergic, Perennial; Safety; Time Factors	1999

Other Studies

1 other study(ies) available for mizolastine and Conjunctivitis, Allergic

Article	Year
Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: a European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study). Allergy, 2001, Volume: 56, Issue:7 Topics: Adolescent; Adult; Benzimidazoles; Child; Cohort Studies; Conjunctivitis, Allergic; Europe; Female; Histamine H1 Antagonists; Humans; Incidence; Male; Middle Aged; Rhinitis, Allergic, Seasonal; Treatment Outcome	2001

Article

Year

Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: a European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study).

Allergy, 2001, Volume: 56, Issue:7

Topics: Adolescent; Adult; Benzimidazoles; Child; Cohort Studies; Conjunctivitis, Allergic; Europe; Female; Histamine H1 Antagonists; Humans; Incidence; Male; Middle Aged; Rhinitis, Allergic, Seasonal; Treatment Outcome

2001